| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,145 |
22,198 |
$1.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,047 |
30,860 |
$1.41M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19,921 |
18,942 |
$1.22M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,582 |
18,343 |
$904K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,595 |
7,906 |
$465K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,874 |
4,437 |
$436K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
9,075 |
8,230 |
$189K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,367 |
2,169 |
$76K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,796 |
2,789 |
$68K |
| 99215 |
Prolong outpt/office vis |
375 |
363 |
$27K |
| 99051 |
|
2,066 |
2,008 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,520 |
1,451 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
237 |
235 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
233 |
228 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
125 |
111 |
$3K |
| 99201 |
|
71 |
71 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
237 |
193 |
$2K |
| 81003 |
|
1,222 |
1,076 |
$2K |
| 73610 |
|
25 |
25 |
$661.23 |
| 87634 |
|
14 |
13 |
$632.70 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
17 |
$570.97 |
| 73630 |
|
13 |
13 |
$322.54 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13 |
12 |
$59.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
53 |
51 |
$52.88 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
12 |
$18.70 |
| 99000 |
|
13 |
12 |
$0.00 |
| 3210F |
|
13 |
13 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
15 |
14 |
$0.00 |